January 17, 2018
Dear Kinamed Agents and Reps,
With all the great opportunities knocking at our doors (see several emails I’ve sent over the last few weeks), we want to be sure you have the best tools to seize the day! We know all too well that it can be one thing to sell the product to surgeons, but another to get past the VAC. To that end, we’ve expanded our CarboJet hospital-facing sales materials and updated some existing pieces.
CarboJet Value Analysis Committee (VAC) Presentation:
Like we did recently with SuperCable, We’ve taken our CarboJet sales presentation for surgeons and translated it for the VAC. This new presentation (linked here) is concise and focused on issues that the “money-people” care about. The new section on real-world analogous compressed gas applications provides a needed dose of “common sense”, and is backed up by several slides on the clinical evidence.
Surgeon request letter
This is newly updated with reference to Meneghini’s tourniquetless TKA/ Opiate study and an increased emphasis on CarboJet’s role in removing lipids/ fatty marrow elements. Linked Here.
White Paper on Aseptic Loosening
This hasn’t been updated, but Combine the items mentioned above with this hospital facing white paper (linked here), and you’ve got a winning recipe for gaining hospital approval!
Remember – If you’re not taking advantage of this CarboJet opportunity, you’re missing out on giving yourself a serious Pay Raise…! And the beauty of CarboJet revenue is that, although it takes some upfront effort like anything else, the revenue stream is relatively easy to maintain and grow because case coverage is not required. You can contact me or your Regional Manager any time to discuss the best way to get started.
Let’s make it happen!
Patrick Miller
Sales & Marketing Manager
Kinamed, Inc.
tel: 1-805-384-2748 x 207
fax: 1-805-384-2792
Confidentiality Notice: The information contained in this email, including any attachments, is intended only for the listed recipient(s) and may be privileged, confidential, and legally protected from disclosure. Dissemination, copying, or use of or reliance upon this email by or to anyone other than the listed recipient(s) is prohibited. If you are not the intended recipient, or if this email has been sent to you in error, please notify the sender immediately and destroy any and all copies of this email including any attachments.